HighTower Advisors’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Buy |
55,876
+166
| +0.3% | +$679 | ﹤0.01% | 3149 |
|
|
2025
Q1 | $95.8K | Hold |
55,710
| – | – | ﹤0.01% | 3339 |
|
|
2024
Q4 | $81.9K | Sell |
55,710
-1,500
| -3% | -$2.21K | ﹤0.01% | 3355 |
|
|
2024
Q3 | $98K | Hold |
57,210
| – | – | ﹤0.01% | 3290 |
|
|
2024
Q2 | $121K | Sell |
57,210
-1,000
| -2% | -$2.12K | ﹤0.01% | 3130 |
|
|
2024
Q1 | $127K | Buy |
58,210
+1,500
| +3% | +$3.27K | ﹤0.01% | 3071 |
|
|
2023
Q4 | $196K | Hold |
56,710
| – | – | ﹤0.01% | 2994 |
|
|
2023
Q3 | $83K | Hold |
56,710
| – | – | ﹤0.01% | 3105 |
|
|
2023
Q2 | $89K | Buy |
56,710
+1,000
| +2% | +$1.57K | ﹤0.01% | 3061 |
|
|
2023
Q1 | $60K | Hold |
55,710
| – | – | ﹤0.01% | 2978 |
|
|
2022
Q4 | $64K | Hold |
55,710
| – | – | ﹤0.01% | 2948 |
|
|
2022
Q3 | $51K | Hold |
55,710
| – | – | ﹤0.01% | 2831 |
|
|
2022
Q2 | $85K | Hold |
55,710
| – | – | ﹤0.01% | 2789 |
|
|
2022
Q1 | $245K | Hold |
55,710
| – | – | ﹤0.01% | 2654 |
|
|
2021
Q4 | $328K | Hold |
55,710
| – | – | ﹤0.01% | 2409 |
|
|
2021
Q3 | $488K | Hold |
55,710
| – | – | ﹤0.01% | 2061 |
|
|
2021
Q2 | $565K | Hold |
55,710
| – | – | ﹤0.01% | 1983 |
|
|
2021
Q1 | $370K | Hold |
55,710
| – | – | ﹤0.01% | 2147 |
|
|
2020
Q4 | $478K | Buy |
55,710
+12,500
| +29% | +$107K | ﹤0.01% | 1645 |
|
|
2020
Q3 | $313K | Hold |
43,210
| – | – | ﹤0.01% | 1795 |
|
|
2020
Q2 | $362K | Hold |
43,210
| – | – | ﹤0.01% | 1610 |
|
|
2020
Q1 | $273K | Hold |
43,210
| – | – | ﹤0.01% | 1604 |
|
|
2019
Q4 | $430K | Buy |
+43,210
| New | +$430K | ﹤0.01% | 1511 |
|